A Practical Nomogram Based on Systemic Inflammatory Markers for Predicting

Status Completed

Clinical Trial Summary

Immunothrombosis has recently been used to describe the responses/mechanisms in thrombosis. Systemic inflammatory markers are prognostic markers for a variety of thrombotic conditions; however, their potential value in predicting portal vein thrombosis (PVT) is unknown. This study aimed to establish an easy-to-use nomogram based on systemic inflammatory markers to predict portal vein thrombosis (PVT) in patients with liver cirrhosis.

Clinical Trial Description

This retrospective study included 478 patients with cirrhosis between January 2013 and January 2021. Reputed systemic inflammatory markers (systemic immune-inflammation index [SII], neutrophil-to-lymphocyte ratio [NLR], monocyte-to-lymphocyte ratio [MLR], and platelet-to-lymphocyte ratio (PLR)) were measured, and the clinical data were recorded. The independent risk factors for PVT were determined using univariate analyses and multivariate logistic regression analyses, and a nomogram to predict the occurrence of PVT was established. The concordance index, receiver operating characteristic curves, and calibration plots were used to evaluate the performance of the model. ;

Study Design

Related Conditions & MeSH terms

Clinical Trial Details

NCT number	NCT05541562
Study type	Observational
Source	The Affiliated Hospital of Qingdao University
Contact
Status	Completed
Phase
Start date	January 1, 2013
Completion date	January 1, 2021

View Details

See also
Status	Clinical Trial	Phase
Not yet recruiting	`NCT03631147` - The Effect of Rifaximin on Portal Vein Thrombosis	N/A
Completed	`NCT02250391` - Placebo-controlled Study of NPB-06 in Patients With Portal Vein Thrombosis	Phase 3
Recruiting	`NCT05625893` - Proton Beam Radiotherapy Followed by Tecentriq and Avastin for Primary Liver Cancer With Vp2-4 Portal Vein Invasion	Phase 2
Completed	`NCT05012501` - Analysis of Neutrophil Extracellular Traps in Hypercoagulability and Portal Vein Thrombosis in Liver Cirrhosis Patients
Terminated	`NCT00769873` - Anticoagulation Post Laparoscopic Splenectomy	Phase 2
Recruiting	`NCT05123326` - Global Coagulation Assessment in Portal Vein Thrombosis and Budd-Chiari Syndrome
Completed	`NCT01095185` - Efficacy of Statin Association With Standard Treatment in Prevention of Recurrent Hemorrhage in Patient With Cirrhosis and Variceal Bleeding	Phase 3
Completed	`NCT02585713` - Apixaban or Dalteparin in Reducing Blood Clots in Patients With Cancer Related Venous Thromboembolism	Phase 3
Not yet recruiting	`NCT06117488` - Risk Factors and Management Outcome of Chronic Portal Vein Thrombosis in Children
Completed	`NCT01326949` - Transjugular Intrahepatic Portosystemic Shunt (TIPS) for Prevention of Variceal Rebleeding in Cirrhotic Patients With Portal Vein Thrombosis	N/A
Not yet recruiting	`NCT05339581` - IMRT Plus PD-1 Blockade and Lenvatinib for HCC With PVTT (Vp3) Before Liver Transplantation	N/A
Recruiting	`NCT03902678` - Role of EUS Guided FNA of Portal Vein Thrombus in the Diagnosis and Staging of Hepatocellular Carcinoma	N/A
Not yet recruiting	`NCT06319131` - Nadroparin Versus TIPS in Cirrhotic Patients With Refractory Asymptomatic PVT	N/A
Recruiting	`NCT03193502` - Efficacy and Safety of Rivaroxaban in the Management of Acute Non-neoplastic PVT Compensated Cirrhosis	Phase 3
Completed	`NCT03201367` - Efficacy and Safety of Rivaroxaban in Acute Non-neoplastic Portal Vein Thrombosis in HCV	N/A
Completed	`NCT03477149` - EASYX-1 : A Multicenter Study on Safety and Efficacy of Easyx Liquid Embolization Agent Used in Five Separate Indications	N/A
Recruiting	`NCT02398357` - The Effect of Anticoagulation After Endoscopic Therapy in Cirrhotic Patients With Portal Vein Thrombosis	Phase 4
Completed	`NCT01556282` - TheraSpheres Treatment for Unresectable Hepatocarcinoma and Portal Vein Thrombosis	N/A
Withdrawn	`NCT01631877` - Efficacy and Safety of Acenocoumarol for Treatment of Nontumor Portal Vein Thrombosis in Cirrhosis of Liver	N/A
Recruiting	`NCT04433481` - Efficacy and Safety of Dabigatran in Patients With Cirrhosis and Portal Vein Thrombosis	N/A

A Practical Nomogram Based on Systemic Inflammatory Markers for Predicting Portal Vein Thrombosis in Patients With Liver Cirrhosis

Clinical Trial Summary

Clinical Trial Description

Study Design

Related Conditions & MeSH terms